KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Cash from Investing Activities (2016 - 2025)

Medpace Holdings (MEDP) has disclosed Cash from Investing Activities for 11 consecutive years, with -$4.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Investing Activities rose 40.85% year-over-year to -$4.5 million, compared with a TTM value of -$31.1 million through Dec 2025, down 10.0%, and an annual FY2025 reading of -$31.1 million, down 10.0% over the prior year.
  • Cash from Investing Activities was -$4.5 million for Q4 2025 at Medpace Holdings, up from -$10.7 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $2.5 million in Q1 2024 and bottomed at -$12.8 million in Q2 2024.
  • Average Cash from Investing Activities over 5 years is -$8.2 million, with a median of -$8.9 million recorded in 2021.
  • The sharpest move saw Cash from Investing Activities skyrocketed 126.62% in 2024, then tumbled 494.74% in 2025.
  • Year by year, Cash from Investing Activities stood at -$9.1 million in 2021, then fell by 1.14% to -$9.2 million in 2022, then increased by 13.26% to -$8.0 million in 2023, then grew by 5.44% to -$7.6 million in 2024, then skyrocketed by 40.85% to -$4.5 million in 2025.
  • Business Quant data shows Cash from Investing Activities for MEDP at -$4.5 million in Q4 2025, -$10.7 million in Q3 2025, and -$6.0 million in Q2 2025.